|
|
| | 2-[2-[(3S)-3-[3-[(E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[(Methanesulfonyl)oxy]propyl]phenyl]-2-propanol Basic information |
| | 2-[2-[(3S)-3-[3-[(E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[(Methanesulfonyl)oxy]propyl]phenyl]-2-propanol Chemical Properties |
| Boiling point | 718.6±60.0 °C(Predicted) | | density | 1.293±0.06 g/cm3(Predicted) | | solubility | DCM | | pka | 14.46±0.29(Predicted) |
| | 2-[2-[(3S)-3-[3-[(E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[(Methanesulfonyl)oxy]propyl]phenyl]-2-propanol Usage And Synthesis |
| Uses | 2-[2-[(3S)-3-[3-[(E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[(methanesulfonyl)oxy]propyl]phenyl]-2-propanol is an intermediate in the synthesis of Montelukast (M568000), a selective leukotriene D4-receptor antagonist used as an antiasthmatic agent. |
| | 2-[2-[(3S)-3-[3-[(E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[(Methanesulfonyl)oxy]propyl]phenyl]-2-propanol Preparation Products And Raw materials |
|